AstraZeneca
Highlights from Future Lab Informatics 2022
November 22 by Leila HawkinsSpeakers from AstraZeneca, Merck, Moderna and Johnson & Johnson on building the lab of the future
Respiratory syncytial virus and the race for a vaccine
November 21 by Leila HawkinsAs cases of RSV surge vaccine manufacturers are racing to find a treatment
Five antiviral Covid treatments are too expensive, says UK government body
November 16 by Leila HawkinsUK agency deems treatments too costly, prompting backlash
Big pharma CEOs announce net zero action plan
November 03 by Leila HawkinsSeven major pharma companies join forces to tackle the sector’s greenhouse gas emissions
“An exciting time for pharma”– Pharma IQ’s panel on the future of drug discovery
October 28 by Leila HawkinsLeading experts came together to discuss the future of pharma in Pharma IQ’s recent webinar
Highlights from Pharma IQ Live: Transforming drug discovery with AI
July 19 by Leila HawkinsKey takeaways from Pharma IQ Live: Transforming drug discovery with AI
Top 10 pharma execs leading sustainability efforts
June 09 by Leila HawkinsPharma IQ lists 10 pharma execs leading efforts to drive sustainability goals
AstraZeneca shares positive results for its drug to lower cholesterol
April 13 by Leila HawkinsPharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death
Keeping tabs on pharma: Landmark new drug approvals and Sanofi’s diversity push
April 05 by Leila HawkinsPharma IQ’s latest round-up has the latest drug approvals for Gilead and AstraZeneca
Keeping tabs on pharma: First precision medicine for autism spectrum disorders
March 28 by Leila HawkinsPharma IQ’s latest news round-up looks at the first precision medicine for autism spectrum disorders, AstraZeneca’s preventative Covid-19 shot and India’s rising cost of medication
Keeping tabs on Covid-19: Big pharma’s response to the global health emergency
August 20 by Emily UwemedimoThe latest developments from Roche, Regeneron, AstraZeneca, Amgen and Merck as they progress with projects to tackle the Covid-19 pandemic
Keeping tabs on Covid-19: Asia lags in vaccine roll outs and new South Korean drug marked as a “game changer”
May 28 by Emily UwemedimoA “game changing” Covid-19 drug from South Korea has been introduced in a world-class academic journal